Clinical trialNCT06098430RecruitingObservational

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

SponsorSt. Jude Children's Research HospitalEnrollment100Nodular Lymphocyte-Predominant Hodgkin Lymphoma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

There is a pressing need to measure patient-reported symptoms in patients of all ages diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). This study aims to measure longitudinal symptom burden and treatment tolerability utilizing validated patient-reported outcomes (PROs) instruments. Primary Objective: * To develop the data collection infrastructure required to prospectively collect longitudinal electronic patient-reported outcomes (PROs) survey instruments in adult and pediatric patients diagnosed with NLPHL. Secondary Objective: * To examine differences in baseline and longitudinal changes in PROs based on disease characteristics, disease status, and treatment strategies among adult and pediatric patients diagnosed with NLPHL.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Ajay Major, MD, MBA
University of Colorado, Denver
Principal Investigator
clinicaltrials.gov ↗
Anna Jones, PhD
St. Jude Children's Research Hospital
Principal Investigator
clinicaltrials.gov ↗
Jamie Flerlage, MD, MS
University of Rochester
Principal Investigator
clinicaltrials.gov ↗
Matthew Rees, MD
St. Jude Children's Research Hospital
Principal Investigator
clinicaltrials.gov ↗
Valerie Crabtree, PhD
St. Jude Children's Research Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Stanford University Medical Center
Palo Alto, California, United States
Michael Binkley, MD
Recruiting
University of Colorado Hospital
Aurora, Colorado, United States
Ajay Major, MD, MBA
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Angela Feraco, MD
Recruiting
Hackensack University Medical Center
Hackensack, New Jersey, United States
Burton Appel, MD, MBA
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Christopher Forlenza, MD
Recruiting
University of Rochester Medical Center
Rochester, New York, United States
Jamie Flerlage, MD, MS
Recruiting
St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
Anna Jones, PhDMatthew Rees, MDValerie Crabtree, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 4 Apr 2024
Primary completion: 31 Dec 2026
Completion: 31 Jan 2028
Last update posted: 20 May 2026
Registered enrollment: 100
Registry id: NCT06098430

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.